ANDA 91104, held by Am Regent. Clonidine Hydrochloride.
As of Nov 16, 2026, ANDA 91104 (Clonidine Hydrochloride), held by Am Regent, was first approved by FDA on Oct 8, 2009, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 8, 2009 | Original application | Approved | None posted |
| Clonidine Hydrochloride1MG/10ML (0.1MG/ML) · injectable;injection | Clonidine Hydrochloride | Discontinued |
| Clonidine Hydrochloride5MG/10ML (0.5MG/ML) · injectable;injection | Clonidine Hydrochloride | Discontinued |
| Jul 21, 2011 | Supplement 2Labeling | Approved | None posted |
| Oct 8, 2009 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters